Common Names: squirting cucumber, exploding cucumber
Phytochemical cucurbitacin E (CuE) may be a promising drug discovery treatment in Alzheimer's disease (AD). This study investigated CuE's effects on TAU fibril formation in okadaic acid-induced AD in rats. Results suggest that CuE contributes to memory gain by reducing TAU protein accumulation. Further evaluations in future preclinical and clinical studies are warranted.
This study evaluated the potential of a Mediterranean plant as a treatment for Alzheimer's disease by testing its anti-inflammatory properties in rats with AD symptoms. They found that the plant had positive effects on both biochemical markers and behavior in the rats. Additionally, the researchers investigated the plant's impact on the NF-κB pathway, which is responsible for inflammation, and found that the plant could potentially reduce inflammation in individuals with AD.
Researchers studied the effects of Ecballium elaterium (EE) on sepsis-associated encephalopathy (SAE), a major clinical challenge in intensive care units. They induced SAE in 30 rats with cecal ligation and puncture (CLP), then divided them into three groups: control, sepsis, and treatment. The treatment group received 2.5 mg/kg of EE. After 24 hours, the brain tissue was analyzed for levels of cytokines, antioxidants, and inflammation. The treatment group showed a statistically significant reduction in brain tissue levels of proinflammatory cytokines and a decrease in histopathologic changes associated with SAE. EE contains components that may help protect against SAE by reducing inflammation.